10X Genomics Inc (TXG) is a Healthcare · Health Information Services company listed on NASDAQ. Price $75.75 (-1.58%), Market cap $3.04B, 52-week low–high $8.17 ~ $26.08.
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This pl
Financial statements, price targets, institutional (13F) holdings and related news for 10X Genomics Inc are updated in real time on BlackAll Trade.
10X Genomics Inc trades at $75.75 (-1.58%). Real-time quotes and charts are available on BlackAll Trade.
10X Genomics Inc has a market cap of about $3.04B.
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and th